Genalyt, a San Diego, CA based startup has raised $36 million in funding led by Khosla Ventures and Redmile Group to expand its one-drop blood test platform, Maverick™ Detection System.Founded in 2007, the Theranos competitor leverages proprietary silicon chip containing arrays of photonic microring sensors to simultaneously analyze multiple proteins/biomarkers from minimal sample volume, which can be utilized inside physician offices by offering laboratory test results in under 15 minutes.
